Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Jul 14, 2016
Insider Transaction Report
Form 4
DOVEY BRIAN H
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2016-07-12+15,000→ 15,000 totalExercise: $4.02Exp: 2026-07-11→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 12, 2016, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date.